NEO — NEOGENOMICS INC

—
Nasdaq · Unknown · Unknown · CIK 1077183 ·
Last close
$15.25
Market Cap
$1.97B
52W High
$20.15
52W Low
$7.07
ADV30
1,805,819
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 209,254,000 96,588,000 -7,941,000 -7,546,000 1,376,917,000 139,281,000 576,279,000
Jun 2026 201,656,000 91,878,000 -9,771,000 2,238,000 1,352,243,000 145,539,000 566,511,000
Mar 2026 186,672,000 80,864,000 -18,241,000 -17,106,000 1,346,531,000 146,143,000 517,771,000
Dec 2025 190,170,000 83,343,000 -12,788,000 -9,881,000 1,359,830,000 159,618,000 523,268,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$4,280,000
Investing CF
$-31,472,000
Financing CF
$2,324,000
CapEx
$-32,863,000
Dividends Paid
—
Buybacks
$-25,000,000
EPS Diluted TTM
$-0.25
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-456,220,000
Inventory
$25,500,000
Receivables
$213,410,000
ST Investments
$0
EBIT TTM
$-32,934,000
Pretax Income TTM
$-36,179,000
Interest Exp TTM
$3,245,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$787,752,000
EBITDA
$30,608,000
Free Cash Flow
$-17,242,124
Enterprise Value
$2,558,648,832
Total Cash
$139,280,992
Total Debt
$449,140,992
Shares Out
129,389,465
Trailing EPS
$-0.24
Book Value
$6.20
ROE
-3.9%
ROA
-1.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 727,332,000 -88,128,000 -108,025,000 1,359,830,000 523,268,000 836,562,000 5,230,000
Dec 2024 660,566,000 -85,448,000 -78,726,000 1,638,038,000 735,699,000 902,339,000 7,023,000
Dec 2023 591,643,000 -96,648,000 -87,968,000 1,681,229,000 739,692,000 941,537,000 -1,953,000
Dec 2022 509,728,000 -153,107,000 -144,250,000 1,740,034,000 742,011,000 998,023,000 -65,993,000

TTM Snapshot

Revenues TTM
$766,295,000
NetIncome TTM
$-51,878,000
OpCashFlow TTM
—
Assets (Latest)
$1,352,243,000
Forward EPS
$0.33

Peers — same industry

TickerNameMarket CapLastDaily %
CPRI Capri Holdings Ltd $1.97B $19.08 —
EVT Eaton Vance Tax-Advantaged Dividend Income Fund $1.96B $26.33 —
LUNR Intuitive Machines, Inc. $1.96B $11.05 —
TBNGY PT Bukit Asam Tbk/ADR $1.96B $4.25 —
AVVSY Avio S.p.A./ADR $1.96B $10.59 —

News headlines (Yahoo Finance, 1h cache)

Did Narrower Quarterly Loss Just Shift NeoGenomics Stock Investment Narrative?
2026-11-06 02:16 · Yahoo
NEO Q3 deep dive: product mix shift and margin expansion drive robust oncology testing growth
2026-11-03 07:57 · Yahoo
5 revealing analyst questions from NeoGenomics’s Q3 earnings call
2026-10-31 19:47 · Yahoo
NeoGenomics (NEO) Beat Q3 Expectations, Is The Stock Still Cheap?
2026-10-29 17:10 · Yahoo
What NeoGenomics (NEO) Said on Its Q3 Earnings Call
2026-10-29 05:04 · Yahoo
NeoGenomics (NEO) Q3 2026 Earnings Call Transcript
2026-10-29 04:13 · Yahoo
NeoGenomics (NEO) Q3 Earnings and Revenues Beat Estimates
2026-10-28 22:30 · Yahoo
NeoGenomics: Q3 Earnings Snapshot
2026-10-28 20:59 · Yahoo
NeoGenomics’s (NASDAQ:NEO) Q3 2026 sales beat estimates
2026-10-28 20:26 · Yahoo
NeoGenomics Reports Third Quarter 2026 Results
2026-10-28 20:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.